About BrainVu
BrainVu is a company based in Hadera (Israel) founded in 2016 was acquired by Mantis Vision in September 2018. BrainVu has raised $577.07 thousand across 1 funding round from investors including Mantis Vision and Nielsen Innovate Fund. BrainVu operates in a competitive market with competitors including GSK, Varjo, Avidity Biosciences, Sutro Biopharma and Ambarella, among others.
- Headquarter Hadera, Israel
-
Sectors
HealthcareTechnology Industrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$577.07 K (USD)
in 1 rounds
-
Latest Funding Round
$577.07 K (USD), Seed
Jan 03, 2018
-
Investors
Mantis Vision
& 1 more
-
Employee Count
Not available
-
Acquired by
Mantis Vision
(Sep 05, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BrainVu
BrainVu has successfully raised a total of $577.07K through 1 strategic funding round. The most recent funding activity was a Seed round of $577.07 thousand completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BrainVu
BrainVu has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Mantis Vision and Nielsen Innovate Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage incubator and investment fund for technology startups.
|
Locked | Locked | Locked | |
|
3D capturing technology is developed for mobile devices and scanners.
|
Locked | Locked | Locked |
Investor details for BrainVu
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BrainVu
Investment portfolio details for BrainVu
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BrainVu
Detailed financials for BrainVu
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brainvu Comparisons
Peer comparison for BrainVu
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BrainVu
BrainVu operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Varjo, Avidity Biosciences, Sutro Biopharma and Ambarella, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Virtual reality headsets are provided for immersive professional applications.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
AI-enabled image processors are manufactured for ADAS and security applications.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
Detailed competitors of BrainVu
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brainvu
Complete news archive for BrainVu
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrainVu
BrainVu was founded in 2016 and raised its 1st funding round 2 years after it was founded.
BrainVu is headquartered in Hadera, Israel. It is registered at Hadera, Central District, Israel.
BrainVu is a funded company, having raised a total of $577.07K across 1 funding round to date.
BrainVu was founded in 2016 in Hadera, Israel, within the machine vision and biotechnology sector. Eye movements are tracked and brain activity is measured through functional magnetic resonance imaging to identify emotions, cognitive load, stress, and engagement. These states are correlated with events to enable human-machine interactions across platforms. Applications include ARVR environments and marketing analytics.
BrainVu's top competitors include Sutro Biopharma, Synthego and Ambarella.
BrainVu has 2 investors. Key investors include Mantis Vision, and Nielsen Innovate Fund.